Doximity, Inc. (NASDAQ:DOCS – Get Free Report) Director Kira Scherer Wampler sold 2,500 shares of the stock in a transaction on Monday, July 1st. The stock was sold at an average price of $28.00, for a total transaction of $70,000.00. Following the completion of the sale, the director now owns 10,258 shares in the company, valued at $287,224. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Kira Scherer Wampler also recently made the following trade(s):
- On Friday, May 17th, Kira Scherer Wampler sold 2,500 shares of Doximity stock. The stock was sold at an average price of $27.22, for a total transaction of $68,050.00.
Doximity Stock Performance
Doximity stock traded down $0.51 during mid-day trading on Tuesday, reaching $26.96. The company’s stock had a trading volume of 2,791,771 shares, compared to its average volume of 1,718,913. The company has a market capitalization of $5.00 billion, a price-to-earnings ratio of 38.17, a price-to-earnings-growth ratio of 5.23 and a beta of 1.22. Doximity, Inc. has a 12 month low of $19.71 and a 12 month high of $36.29. The business’s 50 day simple moving average is $26.70 and its 200 day simple moving average is $27.49.
Analyst Ratings Changes
Several equities research analysts have weighed in on the stock. William Blair reiterated an “outperform” rating on shares of Doximity in a report on Friday, May 17th. JPMorgan Chase & Co. upgraded shares of Doximity from an “underweight” rating to a “neutral” rating and set a $25.00 price objective on the stock in a report on Thursday, April 25th. Morgan Stanley restated an “underweight” rating and set a $25.00 price objective on shares of Doximity in a report on Tuesday, April 23rd. Evercore ISI raised their price objective on shares of Doximity from $28.00 to $29.00 and gave the stock an “in-line” rating in a report on Friday, May 17th. Finally, Needham & Company LLC restated a “hold” rating on shares of Doximity in a report on Friday, May 17th. One investment analyst has rated the stock with a sell rating, eleven have assigned a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Doximity has an average rating of “Hold” and a consensus target price of $28.73.
Get Our Latest Stock Analysis on Doximity
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently modified their holdings of the company. First Horizon Advisors Inc. grew its position in shares of Doximity by 111.3% in the 4th quarter. First Horizon Advisors Inc. now owns 995 shares of the company’s stock valued at $28,000 after acquiring an additional 524 shares during the period. LRI Investments LLC acquired a new stake in shares of Doximity during the 1st quarter worth about $27,000. GAMMA Investing LLC acquired a new stake in shares of Doximity during the 4th quarter worth about $40,000. DekaBank Deutsche Girozentrale acquired a new stake in shares of Doximity during the 1st quarter worth about $46,000. Finally, Essex Investment Management Co. LLC acquired a new stake in shares of Doximity during the 1st quarter worth about $73,000. Institutional investors own 87.19% of the company’s stock.
About Doximity
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Featured Stories
- Five stocks we like better than Doximity
- What is the Australian Securities Exchange (ASX)
- RXO Shares Surge Following New Acquisition Deal
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- How to Use the MarketBeat Excel Dividend Calculator
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.